| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.UCL.2014.01.007 |
| P8608 | Fatcat ID | release_gs7sc4ut6bfktbs46urznempty |
| P932 | PMC publication ID | 3986723 |
| P698 | PubMed publication ID | 24725492 |
| P2093 | author name string | Edward K. Chang | |
| Leonard S. Marks | |||
| Samuel K. Stephenson | |||
| P2860 | cites work | Prostate biopsy: past, present, and future | Q39791080 |
| Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer | Q39915271 | ||
| Active surveillance program for prostate cancer: an update of the Johns Hopkins experience | Q45133435 | ||
| A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion | Q45389556 | ||
| Focal therapy for localized prostate cancer: a phase I/II trial | Q50246484 | ||
| Real time MRI-ultrasound image guided stereotactic prostate biopsy | Q74461089 | ||
| Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer | Q80609479 | ||
| Mechanically assisted 3D ultrasound guided prostate biopsy system | Q83253118 | ||
| Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers | Q83423979 | ||
| Characterizing clinically significant prostate cancer using template prostate mapping biopsy | Q84378694 | ||
| Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population | Q84592313 | ||
| Clinical application of a 3D ultrasound-guided prostate biopsy system | Q24608010 | ||
| ESUR prostate MR guidelines 2012 | Q24620926 | ||
| Active surveillance for prostate cancer: progress and promise | Q28245173 | ||
| Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study | Q30514532 | ||
| Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges | Q30977250 | ||
| Time trends and local variation in primary treatment of localized prostate cancer | Q33710948 | ||
| Contemporary trends in low risk prostate cancer: risk assessment and treatment | Q34330041 | ||
| MRI-ultrasound fusion for guidance of targeted prostate biopsy | Q34645142 | ||
| Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging | Q35354750 | ||
| Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device | Q36579232 | ||
| Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies | Q37149144 | ||
| Use of advanced treatment technologies among men at low risk of dying from prostate cancer. | Q37378693 | ||
| Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen | Q37381526 | ||
| Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer | Q37866554 | ||
| Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study | Q38098361 | ||
| Anatomy and pathology of the male pelvis by magnetic resonance imaging | Q38536548 | ||
| Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. | Q39278530 | ||
| Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients | Q39685186 | ||
| The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? | Q39694955 | ||
| Improved prostate cancer detection with anterior apical prostate biopsies | Q39776971 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biopsy | Q179991 |
| P304 | page(s) | 315-26 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | Urologic Clinics of North America | Q15767454 |
| P1476 | title | Screening and detection advances in magnetic resonance image-guided prostate biopsy | |
| P478 | volume | 41 |
| Q37109441 | Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening. |
| Q92212376 | Accuracy of multiparametric magnetic resonance imaging for diagnosing prostate Cancer: a systematic review and meta-analysis |
| Q37029385 | Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools |
| Q53513394 | Clinical utility of transperineal template-guided mapping biopsy of the prostate after negative magnetic resonance imaging-guided transrectal biopsy. |
| Q64912188 | Comparison of diagnostic value of multi-slice spiral CT and MRI for different pathological stages of prostate cancer. |
| Q38379141 | Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer |
| Q36173279 | MRI-guided focal therapy of prostate cancer |
| Q37018444 | Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer |
| Q38806269 | Multiparametric magnetic resonance imaging-transrectal ultrasound fusion prostate biopsy: A prospective, single centre study |
| Q55258148 | Multiparametric magnetic resonance imaging: Overview of the technique, clinical applications in prostate biopsy and future directions. |
| Q38408501 | Prostate-specific antigen-based prostate cancer screening: Past and future |
| Q38504909 | The role of MRI in active surveillance for prostate cancer |
| Q48263594 | Validating multiparametric MRI for diagnosis and monitoring of prostate cancer in patients for active surveillance. |
Search more.